AI made execution free. Knowing first is the whole game now.
The advantage goes to whoever is first into the right conversations, most often. Fundz stacks those odds: more of the moments that create demand than anyone else catches, as they happen, matched to who you sell to, with the decision maker to call. Now it answers in Claude too: ask for today’s leads and who to reach, then write the note in the same window. Not a feed. Not a list you rent. A system for being first.
Trusted by
OracleSnowflakeCloudflareLinkedInGoogleSalesforce
★★★★★4.8/5 on G2· Since 2015
Valion Bio Appoints Dean Zikria as Interim CEO
PRIVATESep 23, 2026•about 3 hours ago
Position
Chief Executive Officer
Company
Valion Bio
Dean Zikria
BiotechnologyHealth Care
Description
On September 22, 2026, Valion Bio, Inc. appointed Dean Zikria as Interim Chief Executive Officer of the Company, effective immediately. Zikria has been a director on the Company’s Board since July 10, 2019
Company Information
Company
Valion Bio
About
Valion Bio, Inc. is a Delaware corporation focused on advancing treatments for allergy, asthma, and other chronic diseases. The company aims to innovate in the MedTech industry. Valion Bio is dedicated to improving patient outcomes through targeted solutions.
Fundz sees it the moment Valion Bio changes its leadership, hires an exec or expands, usually minutes after it happens, and tells you who to reach.